{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:47:05Z","timestamp":1760057225137,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ajem.2021.05.053","type":"journal-article","created":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T11:50:27Z","timestamp":1621770627000},"page":"318-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19"],"prefix":"10.1016","volume":"54","author":[{"given":"Oscar M.P.","family":"Jolobe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2021.05.053_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2021.05.001","article-title":"Thrombotic thrombocytopenic purpura after Ad26.COV2-S","author":"Yocum","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2021.05.053_bb0010","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021","author":"See","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2021.05.053_bb0015","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.CoV 2.5 vaccination","author":"Muir","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.05.053_bb0020","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.ajem.2021.05.053_bb0025","article-title":"Vaccine-induced immune thrombotic thrombocytopenia(VITT) following adenovirus vector COVID-19 vaccination","volume":"2","author":"Pai","year":"2021","journal-title":"Sci Br"},{"year":"2021","series-title":"CDC COVID-19 vaccine task force vaccine safety team thrombosis with thrombocytopenia syndrome(TTS) following Janssen COVID-19 vaccine advisory committee on immunization practices","author":"Shimabukuro","key":"10.1016\/j.ajem.2021.05.053_bb0030"},{"author":"Pavord","key":"10.1016\/j.ajem.2021.05.053_bb0035"},{"key":"10.1016\/j.ajem.2021.05.053_bb0040","article-title":"Syndrome of cerebral venous sinus thrombosis and thrombocytopenia after vaccination for COVID-19","author":"Soleimani","year":"2021","journal-title":"Res Square"},{"key":"10.1016\/j.ajem.2021.05.053_bb0045","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet Factor 4 after ChAdOx1 nVoV-19 vaccination","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.05.053_bb0050","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.05.053_bb0055","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.05.053_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","author":"Bayas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2021.05.053_bb0065","article-title":"Left inferior ophthalmic vein thrombosis due to VITT(Vaccine Induced Thrombotic Thrombocytopenia): a case report","author":"McDonnell","year":"2021","journal-title":"QJMed"},{"key":"10.1016\/j.ajem.2021.05.053_bb0070","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccine","author":"Thiede","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ajem.2021.05.053_bb0075","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/jcm10081599","article-title":"Thrombocytopenia and intracranial venous sinus thrombosis after \u201cCOVID-19 vaccine AstraZeneca\u201d exposure","volume":"10","author":"Wolf","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajem.2021.05.053_bb0080","article-title":"Fatal cerebral haemorrhage after COVID-19 vaccine","author":"Bjornstad-Tuveng","year":"2021","journal-title":"Tidskriftet Den Norske Legeforening Tidsskr Nor Legeforen"},{"key":"10.1016\/j.ajem.2021.05.053_bb0085","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.thromres.2021.04.001","article-title":"Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination","volume":"202","author":"Franchini","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajem.2021.05.053_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)00871-0","article-title":"Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination","author":"Muster","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2021.05.053_bb0095","article-title":"Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine","author":"Blauenfeldt","year":"2021","journal-title":"Res Square"},{"key":"10.1016\/j.ajem.2021.05.053_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab237","article-title":"COVID-19 vaccine induced prothrombotic immune thrombocytopenia","author":"Xie","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajem.2021.05.053_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/jth.15346","article-title":"Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia(VIPIT)","author":"Thaler","year":"2021","journal-title":"J Thromb Hemost"},{"key":"10.1016\/j.ajem.2021.05.053_bb0110","article-title":"Malignant cerebral infarction, systemic vnous thrombosis and thrombocytopenia after ChAdOx1 nCoV vaccination: a possible catastrophic variant of vaccine-induced thrombotic thrombocytopenia","author":"De Michele","year":"2021","journal-title":"Res Square"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572100437X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572100437X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:02:44Z","timestamp":1760025764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073567572100437X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":22,"alternative-id":["S073567572100437X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.05.053","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.05.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}